Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.

MLA

Norris, Ross L., et al. “Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development.” Therapeutic Drug Monitoring, vol. 32, no. 5, Oct. 2010, pp. 615–23. EBSCOhost, https://doi.org/10.1097/FTD.0b013e3181ea3e8a.

APA

Norris, R. L., Martin, J. H., Thompson, E., Ray, J. E., Fullinfaw, R. O., Joyce, D., Barras, M., Jones, G. R., & Morris, R. G. (2010). Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development. Therapeutic Drug Monitoring, 32(5), 615–623. https://doi.org/10.1097/FTD.0b013e3181ea3e8a

Chicago

Norris, Ross L, Jennifer H Martin, Erin Thompson, John E Ray, Robert O Fullinfaw, David Joyce, Michael Barras, Graham R Jones, and Raymond G Morris. 2010. “Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development.” Therapeutic Drug Monitoring 32 (5): 615–23. doi:10.1097/FTD.0b013e3181ea3e8a.